BIODIVERSITY CONSERVATION & DRUG DISCOVERY IN MADAGASCAR

生物多样性保护

• 批准号: 6805131
• 负责人: DAVID GEORGE IAN KINGSTON
• 金额: $ 72.65万
• 依托单位: VIRGINIA POLYTECHNIC INST AND ST UNIV
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-09-30 至 2008-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6805131
• 关键词: agriculture; aquatic organism; biological products; cardiovascular system; clinical research; cooperative study; drug discovery /isolation; endocrinology; field study; gastrointestinal system; geographic site; immunology; international cooperation; malaria; medicinal plants; microorganism; microorganism culture; neurology; oncology; plant ecology; respiratory system; saltwater environment; sample collection; socioeconomics; training; tuberculosis

DESCRIPTION (provided by applicant): The overall goals of this International Cooperative Biodiversity group are to achieve the threefold mission of biodiversity conservation, economic development, and drug discovery in Madagascar. The proposed research integrates the work of seven different associate programs into a coherent whole to achieve these goals. The drug discovery mission will have a threefold approach to collecting biomaterials in Madagascar. Plants will be collected by botanists from Missouri Botanical Garden (MBG) Conservation International (CI) and the Centre National d'Application et des Recherches Pharmaceutiques (CNARP). Marine organisms will be collected by teams from Centre National de Recherches sur l'Environnement (CNRE) and Centre National de Recherches Oceanographiques (CNRO). Microbial strain isolation from soil samples will be carried out by scientists from CNARP after receiving training at DowAgroSciences (DAS). The plants will be extracted by workers at the CNARP, and the marine organisms will be extracted by workers at CNRE and CNRO. Subsequent bioassays, fractionation studies, and chemistry will be carried out by CNARP, Eisai Research Institute (ERI), DAS and Virginia Polytechnic Institute and State University (VPISU) in the interest areas of cancer, immunology, malaria, neurological disease, tuberculosis, and agrochemistry, and royalties will be paid to Madagascar on sales of any pharmaceuticals or agrochemicals that are developed from this work. Pure microbial strains will be cultured by one or both of the industrial partners, and active compounds of interest will then be isolated from these culture broths. In addition to the drug discovery work outlined above, the Group will also carry out economic development and biodiversity conservation initiatives in Madagascar. In Madagascar the work will include the completion of biodiversity surveys of well-defined forest preserves, as well as training in botanical methods at MBG, training in microbial techniques at DAS, and training in natural product isolation at VPISU. The work will also involve local stakeholders in decisions about the use of upfront funds contributed by DAS and ERI.

描述（由申请人提供）：该国际生物多样性合作小组的总体目标是实现马达加斯加生物多样性保护、经济发展和药物发现的三重使命。拟议的研究将七个不同的副项目的工作整合为一个连贯的整体，以实现这些目标。药物发现任务将采用三重方法在马达加斯加收集生物材料。植物将由密苏里植物园 (MBG)、保护国际 (CI) 和国家应用与药物研究中心 (CNARP) 的植物学家收集。海洋生物将由国家环境研究中心 (CNRE) 和国家海洋研究中心 (CNRO) 的团队收集。 CNARP 的科学家在陶氏益农 (DAS) 接受培训后，将从土壤样本中分离微生物菌株。植物将由 CNARP 的工作人员提取，海洋生物将由 CNRE 和 CNRO 的工作人员提取。随后的生物测定、分级研究和化学将由 CNARP、卫材研究所 (ERI)、DAS 和弗吉尼亚理工学院及州立大学 (VPISU) 在癌症、免疫学、疟疾、神经系统疾病、结核病和农业化学等感兴趣领域进行，任何药品或药物的销售将向马达加斯加支付特许权使用费。 从这项工作中开发的农用化学品。纯微生物菌株将由一个或两个工业合作伙伴培养，然后从这些培养液中分离出感兴趣的活性化合物。除上述药物发现工作外，集团还将在马达加斯加开展经济发展和生物多样性保护举措。在马达加斯加，工作将包括完成对明确森林保护区的生物多样性调查，以及在 MBG 进行植物学方法培训、在 DAS 进行微生物技术培训以及在 VPISU 进行天然产物分离培训。这项工作还将让当地利益相关者参与有关 DAS 和 ERI 提供的前期资金的使用的决策。